By profiling both a biallelic loss of function and overexpression model of INPP5D, we find that microglia in the AD brain most closely resemble the loss-of-function iMG model with regard to effects on immune pathways, supporting the hypothesis that microglia in the AD brain have reduced INPP5D function. This evidence concerns the gene INPP5D and Alzheimer disease.